Skip to Content

New Drug Approvals Archive - March 2006

March 2006

Yaz (drospirenone and ethinyl estradiol) Tablets

Date of Approval: March 16, 2006
Company: Berlex, Inc.
Treatment for: Acne, Contraception, Premenstrual Dysphoric Disorder

Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.

Yaz (drospirenone and ethinyl estradiol) Tablets

Date of Approval: March 16, 2006
Company: Berlex, Inc.
Treatment for: Acne, Contraception, Premenstrual Dysphoric Disorder

Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.

Yaz (drospirenone and ethinyl estradiol) Tablets

Date of Approval: March 16, 2006
Company: Berlex, Inc.
Treatment for: Acne, Contraception, Premenstrual Dysphoric Disorder

Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.

New Drug Approvals Archive

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.